183 related articles for article (PubMed ID: 31578820)
21. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
Dai Y; Jiao H; Teng G; Wang W; Zhang R; Wang Y; Hebbard L; George J; Qiao L
Mol Cancer Ther; 2014 May; 13(5):1206-16. PubMed ID: 24651526
[TBL] [Abstract][Full Text] [Related]
22. CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function.
Chun E; Lavoie S; Michaud M; Gallini CA; Kim J; Soucy G; Odze R; Glickman JN; Garrett WS
Cell Rep; 2015 Jul; 12(2):244-57. PubMed ID: 26146082
[TBL] [Abstract][Full Text] [Related]
23. IL-6 deficiency promotes colitis by recruiting Ly6C
Cao Q; Lin Y; Yue C; Wang Y; Quan F; Cui X; Bi R; Tang X; Yang Y; Wang C; Li X; Gao X
Eur J Pharmacol; 2021 Aug; 904():174165. PubMed ID: 33979652
[TBL] [Abstract][Full Text] [Related]
24. Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis.
Assi K; Mills J; Owen D; Ong C; St Arnaud R; Dedhar S; Salh B
Gut; 2008 Jul; 57(7):931-40. PubMed ID: 18326560
[TBL] [Abstract][Full Text] [Related]
25. Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling.
Woo JK; Jang YS; Kang JH; Hwang JI; Seong JK; Lee SJ; Jeon S; Oh GT; Lee HY; Oh SH
Oncotarget; 2016 May; 7(20):29592-604. PubMed ID: 27127177
[TBL] [Abstract][Full Text] [Related]
26. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice.
Popivanova BK; Kostadinova FI; Furuichi K; Shamekh MM; Kondo T; Wada T; Egashira K; Mukaida N
Cancer Res; 2009 Oct; 69(19):7884-92. PubMed ID: 19773434
[TBL] [Abstract][Full Text] [Related]
27. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
[TBL] [Abstract][Full Text] [Related]
28. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.
Ohnishi T; Hashizume C; Taniguchi M; Furumoto H; Han J; Gao R; Kinami S; Kosaka T; Okazaki T
FASEB J; 2017 Sep; 31(9):3816-3830. PubMed ID: 28522594
[TBL] [Abstract][Full Text] [Related]
29. Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway.
Hachiya K; Masuya M; Kuroda N; Yoneda M; Tsuboi J; Nagaharu K; Nishimura K; Shiotani T; Ohishi K; Tawara I; Katayama N
Sci Rep; 2021 Oct; 11(1):19943. PubMed ID: 34620946
[TBL] [Abstract][Full Text] [Related]
30. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
[TBL] [Abstract][Full Text] [Related]
31. Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction.
Dash R; Bhoopathi P; Das SK; Sarkar S; Emdad L; Dasgupta S; Sarkar D; Fisher PB
Cancer Res; 2014 Jan; 74(2):563-74. PubMed ID: 24282278
[TBL] [Abstract][Full Text] [Related]
32. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
33. SARI, a novel target gene of glucocorticoid receptor, plays an important role in dexamethasone-mediated killing of B lymphoma cells.
Huang Y; Zhou J; Huang Y; He J; Wang Y; Yang C; Liu D; Zhang L; He F
Cancer Lett; 2016 Apr; 373(1):57-66. PubMed ID: 26808579
[TBL] [Abstract][Full Text] [Related]
34. MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth.
Phinney BB; Ray AL; Peretti AS; Jerman SJ; Grim C; Pinchuk IV; Beswick EJ
Front Immunol; 2018; 9():1857. PubMed ID: 30298062
[TBL] [Abstract][Full Text] [Related]
35. Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN).
Su ZZ; Lee SG; Emdad L; Lebdeva IV; Gupta P; Valerie K; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20906-11. PubMed ID: 19074269
[TBL] [Abstract][Full Text] [Related]
36. Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells.
Zhang S; Rong P; Chen Q; Wang W
Life Sci; 2019 Sep; 232():116626. PubMed ID: 31276688
[TBL] [Abstract][Full Text] [Related]
37. Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells.
Fisher RC; Bellamkonda K; Alex Molina L; Xiang S; Liska D; Sarvestani SK; Chakrabarti S; Berg A; Jorgensen ML; Hatala D; Chen S; Aiello A; Appelman HD; Scott EW; Huang EH
Neoplasia; 2019 Mar; 21(3):269-281. PubMed ID: 30738331
[TBL] [Abstract][Full Text] [Related]
38. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.
Lin S; Wang D; Iyer S; Ghaleb AM; Shim H; Yang VW; Chun J; Yun CC
Gastroenterology; 2009 May; 136(5):1711-20. PubMed ID: 19328876
[TBL] [Abstract][Full Text] [Related]
39. Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth.
Ma X; Aoki T; Tsuruyama T; Narumiya S
Cancer Res; 2015 Jul; 75(14):2822-32. PubMed ID: 26018088
[TBL] [Abstract][Full Text] [Related]
40. Turn-over of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2- or double knockout mice.
Schilling M; Strecker JK; Ringelstein EB; Kiefer R; Schäbitz WR
Exp Neurol; 2009 Oct; 219(2):583-5. PubMed ID: 19615366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
